FI20106031A0 - Förfarande för isolering av celler och cellpopulation som isolerats genom förfarandet - Google Patents

Förfarande för isolering av celler och cellpopulation som isolerats genom förfarandet

Info

Publication number
FI20106031A0
FI20106031A0 FI20106031A FI20106031A FI20106031A0 FI 20106031 A0 FI20106031 A0 FI 20106031A0 FI 20106031 A FI20106031 A FI 20106031A FI 20106031 A FI20106031 A FI 20106031A FI 20106031 A0 FI20106031 A0 FI 20106031A0
Authority
FI
Finland
Prior art keywords
cell population
isolating cells
population isolated
isolated
isolating
Prior art date
Application number
FI20106031A
Other languages
English (en)
Finnish (fi)
Inventor
Annika Kotovuori
Suvi Natunen
Leena Valmu
Original Assignee
Suomen Punainen Risti Veripalv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalv filed Critical Suomen Punainen Risti Veripalv
Priority to FI20106031A priority Critical patent/FI20106031A0/sv
Publication of FI20106031A0 publication Critical patent/FI20106031A0/sv
Priority to PCT/FI2011/050862 priority patent/WO2012045913A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20106031A 2010-10-06 2010-10-06 Förfarande för isolering av celler och cellpopulation som isolerats genom förfarandet FI20106031A0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20106031A FI20106031A0 (sv) 2010-10-06 2010-10-06 Förfarande för isolering av celler och cellpopulation som isolerats genom förfarandet
PCT/FI2011/050862 WO2012045913A1 (en) 2010-10-06 2011-10-06 Method for isolating cells and a cell population thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20106031A FI20106031A0 (sv) 2010-10-06 2010-10-06 Förfarande för isolering av celler och cellpopulation som isolerats genom förfarandet

Publications (1)

Publication Number Publication Date
FI20106031A0 true FI20106031A0 (sv) 2010-10-06

Family

ID=43064191

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20106031A FI20106031A0 (sv) 2010-10-06 2010-10-06 Förfarande för isolering av celler och cellpopulation som isolerats genom förfarandet

Country Status (2)

Country Link
FI (1) FI20106031A0 (sv)
WO (1) WO2012045913A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3227310T3 (da) 2014-12-03 2019-09-30 Glycomimetics Inc Heterobifunktionelle inhibitorer af e-selektiner og cxcr4-kemokin-receptorer
US20180320136A1 (en) * 2015-11-03 2018-11-08 GlycoMimitics, Inc. Methods and compositions for the production of monoclonal antibodies, hematopoietic stem cells, and methods of using the same
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
WO2018068010A1 (en) 2016-10-07 2018-04-12 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
EP3596096A1 (en) 2017-03-15 2020-01-22 GlycoMimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
AU2018395417B2 (en) 2017-12-29 2023-07-13 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CA3091454A1 (en) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008087259A1 (en) * 2007-01-18 2008-07-24 Suomen Punainen Risti, Veripalvelu Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof

Also Published As

Publication number Publication date
WO2012045913A1 (en) 2012-04-12

Similar Documents

Publication Publication Date Title
FI20106031A0 (sv) Förfarande för isolering av celler och cellpopulation som isolerats genom förfarandet
DK2699593T3 (da) Beta-2 mikroglobulin-deficiente celler
DK3168295T3 (da) Celledyrkningsmedium, der omfatter små peptider
DK2668680T3 (da) Transparente fotovoltaiske celler
BR112012032164A2 (pt) meio de cultura celular definido quimicamente e isento de soro
DK2574677T3 (da) Fremgangsmåder til celledyrkning
DK3287525T3 (da) RNA-præparater omfattende oprenset modificeret RNA til omprogrammering af celler
EP2624312A4 (en) Solar cell module and method of manufacturing thereof
EP2612369A4 (en) Solar cell and method for manufacturing the same
BR112013016307A2 (pt) adesivo para folha de suporte de bateria solar
EP2577749A4 (en) Apparatus and methods for fast chemical electrodeposition for fabrication of solar cells
DK2548256T3 (da) Elektrokemisk cellestak
BR112012027715A2 (pt) método e célula fotovoltaica
ES2609638T8 (es) Poración celular
DK2685554T3 (da) Siliciumdioxid-solcelle
EP2715801A4 (en) SOLAR CELL AND MANUFACTURING METHOD THEREFOR
DK2704741T3 (da) Fremgangsmåder til håndtering af biologiske lægemidler indeholdende levende celler
FI20075030A0 (sv) Förfarande för modifiering av celler
EP2562824A4 (en) Circuit stack structure of photovoltaic assembly
EP2664009A4 (en) SOLAR MONITORING FOR A CONCENTRATED PHOTOVOLTAIC SYSTEM IMPROVING THE PARTIAL VOLTAGES OF CELLS
EP2618382A4 (en) Solar cell and manufacturing method thereof
DK2511369T3 (da) Proteasestabile cellevægslyserende enzymer
EP2685578A4 (en) CASE COVER, CONSTRUCTION STRUCTURE FOR A GRIND COVER, MANUFACTURING METHOD THEREFOR, CONSTRUCTION PROCESS THEREFOR AND METHOD FOR ADJUSTING A SUSPENSION
EP2619800A4 (en) Solar cell and method for manufacturing the same
EP2503599A4 (en) Solar cell and method for manufacturing same

Legal Events

Date Code Title Description
FD Application lapsed